These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
6. Regarding: "Management of glomerular proteinuria: a commentary". Brenner BM J Am Soc Nephrol; 2004 May; 15(5):1354-5; discussion 1356-7. PubMed ID: 15100378 [No Abstract] [Full Text] [Related]
7. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure]. Pawlak K; Pawlak D; Myśliwiec M Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure. Zucchelli P; Zuccalà A; Gaggi R Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208 [No Abstract] [Full Text] [Related]
10. ACE-inhibitors: panacea for progressive renal disease. Navis G; de Zeeuw D; de Jong PE Lancet; 1997 Jun; 349(9069):1852-3. PubMed ID: 9217751 [No Abstract] [Full Text] [Related]
11. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation. Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome. Zhang Y; Wang F; Ding J; Zhang H; Liu X; Wang S; Xiao H; Yao Y; Liu J; Zhong X; Guan N; Su B; Wu G; Yu L Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473 [TBL] [Abstract][Full Text] [Related]
13. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Jacobson SH; Egberg N; Hylander B; Lundahl J Am J Nephrol; 2002; 22(1):42-7. PubMed ID: 11919402 [TBL] [Abstract][Full Text] [Related]
15. Effect of hemodialysis on plasma levels of vascular endothelial markers. Naumnik B; Borawski J; Pawlak K; Myśliwiec M Clin Appl Thromb Hemost; 2002 Jul; 8(3):245-50. PubMed ID: 12361202 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia. Hagag AA; Abdel-Lateef AE; Aly R J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921 [TBL] [Abstract][Full Text] [Related]
17. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors. Kanno Y; Takenaka T; Nakamura T; Suzuki H Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280 [TBL] [Abstract][Full Text] [Related]
18. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease. Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease. Wapstra FH; Navis G; de Jong PE; de Zeeuw D Exp Nephrol; 1996; 4 Suppl 1():47-52. PubMed ID: 9001897 [TBL] [Abstract][Full Text] [Related]
20. Renoprotective effects of renin-angiotensin-system inhibitors. Mann JF; Ritz E; Kunz R Lancet; 2006 Mar; 367(9514):900; author reply 900-2. PubMed ID: 16546535 [No Abstract] [Full Text] [Related] [Next] [New Search]